FEBS Letters
Volume 582, Issue 5 , Pages 666-672, 5 March 2008

Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus

Edited by Jacomine Krijnse-Locker

  • Marion Kaspari

      Affiliations

    • Institute of Virology, Charité Campus Mitte, Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
  • ,
  • Nina Tavalai

      Affiliations

    • Institut of Clinical and Molecular Virology, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
  • ,
  • Thomas Stamminger

      Affiliations

    • Institut of Clinical and Molecular Virology, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
  • ,
  • Albert Zimmermann

      Affiliations

    • Institute of Virology, Heinrich-Heine-Universität Düsseldorf, Germany
  • ,
  • Rita Schilf

      Affiliations

    • Institute of Virology, Charité Campus Mitte, Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
  • ,
  • Elke Bogner

      Affiliations

    • Institute of Virology, Charité Campus Mitte, Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Fax: +49 30 450 525907.

Received 20 December 2007; received in revised form 14 January 2008; accepted 24 January 2008. published online 31 January 2008.

Abstract 

This study provides evidence that proteasomal activity is required at multiple steps in human cytomegalovirus replication. Electron microscopy revealed that no viral particles were assembled in the presence of proteasome inhibitor MG132. Immunofluorescence and Western blot analyses using MG132 demonstrated that immediate early gene expression was suppressed at low but not high MOI. In contrast, expression of late proteins was completely blocked independent of MOI. Additionally, pulsed-field gel electrophoresis demonstrated that MG132 interferes with cleavage of HCMV DNA. Bromodeoxyuridine incorporation studies showed that de novo viral DNA synthesis is reduced in the presence of MG132. Furthermore, in contrast to previous hypotheses we demonstrated that neither the ND10 components PML and hDaxx nor NFκB activation represent the target for MG132.

Keywords: Human cytomegalovirus, Viral DNA replication, Proteasome inhibitors, Antiviral target

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(08)00065-3

doi:10.1016/j.febslet.2008.01.040

FEBS Letters
Volume 582, Issue 5 , Pages 666-672, 5 March 2008